About UDP-glucuronic acid decarboxylase 1
UDP-glucuronic acid decarboxylase 1 (UXS1) is a protein
from Homo sapiens identified by UniProt accession
Q8NBZ7, 420 residues long.
MolForge cross-references it against 0 known binders and
113 disease associations.
Target properties
| Protein name | UDP-glucuronic acid decarboxylase 1 |
| UniProt accession | Q8NBZ7 |
| Gene | UXS1 |
| Organism | Homo sapiens |
| Length | 420 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (113)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.37
- blood protein measurement · score 0.26
- sitting height measurement · score 0.22
- appendicular lean mass · score 0.22
- neurofibrillary tangles measurement · score 0.21
- BMI-adjusted hip circumference · score 0.21
- leukocyte count · score 0.20
- body height · score 0.19
- colorectal carcinoma · score 0.16
- esophageal carcinoma · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NBZ7-F1 | alphafold | PREDICTED | 89.71 | — |
Amino-acid sequence (420 residues)
MVSKALLRLV SAVNRRRMKL LLGIALLAYV ASVWGNFVNM RSIQENGELK IESKIEEMVE PLREKIRDLE KSFTQKYPPV KFLSEKDRKR ILITGGAGFV GSHLTDKLMM DGHEVTVVDN FFTGRKRNVE HWIGHENFEL INHDVVEPLY IEVDQIYHLA SPASPPNYMY NPIKTLKTNT IGTLNMLGLA KRVGARLLLA STSEVYGDPE VHPQSEDYWG HVNPIGPRAC YDEGKRVAET MCYAYMKQEG VEVRVARIFN TFGPRMHMND GRVVSNFILQ ALQGEPLTVY GSGSQTRAFQ YVSDLVNGLV ALMNSNVSSP VNLGNPEEHT ILEFAQLIKN LVGSGSEIQF LSEAQDDPQK RKPDIKKAKL MLGWEPVVPL EEGLNKAIHY FRKELEYQAN NQYIPKPKPA RIKKGRTRHS
Explore UDP-glucuronic acid decarboxylase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets